Insights

3 of the best ASX healthcare shares to buy and hold

Here’s why I think CSL Limited (ASX:CSL) and these ASX healthcare shares are among the best on offer in the sector right now…
The post 3 of the best ASX healthcare shares to buy and hold appeared first on Motley Fool Australia. –

variety of vitamin pills representing Vita Life share price

If you’re looking for long term investment term options, then I think the healthcare sector would be a great place to start your search.

This is because with populations around the world getting older and chronic disease burden increasing, I expect demand for healthcare services to grow at a consistently solid rate over the next couple of decades.

With that in mind, listed below are three top ASX healthcare shares that I feel could be great long-term options. Here’s why I would buy them:

CSL Limited (ASX: CSL)

If you were to only buy one healthcare share, I would make it CSL. I believe this biotherapeutics giant is perfectly positioned to deliver solid sales and earnings growth over the long term. This is due to its leading therapies, expansive plasma collection network, and promising research and development pipeline. The latter includes a number of therapies which have significant market opportunities.

Ramsay Health Care Limited (ASX: RHC)

Another healthcare share to consider buying and holding is Ramsay Health Care. Times may be hard for the private hospital operator now because of the pandemic, but I believe this is already built into its share price. In light of this, I think investors should focus on the very positive long term outlook its sprawling global network has from the aforementioned industry tailwinds.

ResMed Inc. (ASX: RMD)

A final healthcare share to consider buying is ResMed. I believe this sleep treatment focused medical device company has the potential to grow its earnings at an above average rate for many years to come. This is thanks to its growing and lucrative market opportunity and its leading hardware and software solutions. In respect to the former, management estimates that there are 936 million people with sleep apnoea globally and over 380 million people who suffer from chronic obstructive pulmonary disease (COPD).

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 3 of the best ASX healthcare shares to buy and hold appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!